{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:22:19Z","timestamp":1791350539899,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003545","name":"University of Malaya and Ministry of Science, Technology and Innovation","doi-asserted-by":"publisher","award":["ER016-2013A"],"award-info":[{"award-number":["ER016-2013A"]}],"id":[{"id":"10.13039\/501100003545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.antiviral.2014.05.019","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T01:46:53Z","timestamp":1402537613000},"page":"173-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Inhibitory effects of a peptide-fusion protein (Latarcin\u2013PAP1\u2013Thanatin) against chikungunya virus"],"prefix":"10.1016","volume":"108","author":[{"given":"Hussin A.","family":"Rothan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirbod","family":"Bahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esaki M.","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorsaadah Abd","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohana","family":"Yusof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.antiviral.2014.05.019_b0005","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/AAC.17.6.1032","article-title":"Inhibition of herpes simplex virus multiplication by the pokeweed antiviral protein","volume":"17","author":"Aron","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.antiviral.2014.05.019_b0010","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1177\/1087057111402825","article-title":"The use of real-time cell analyzer technology in drug discovery: defining optimal cell culture conditions and assay reproducibility with different adherent cellular models","volume":"16","author":"Atienzar","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.antiviral.2014.05.019_b0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2334-13-67","article-title":"Emergence of chikungunya seropositivity in healthy Malaysian adults residing in outbreak-free locations: chikungunya seroprevalence results from the Malaysian Cohort","volume":"13","author":"Azami","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.05.019_b0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0192-0561(95)00068-D","article-title":"Preclinical evaluation of the ribosome-inactivating proteins PAP-1, PAP-S and RTA in mice","volume":"17","author":"Benigni","year":"1995","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.antiviral.2014.05.019_b0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cbdd.12055","article-title":"The Future of peptide-based drugs","volume":"81","author":"Craik","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.antiviral.2014.05.019_b0030","doi-asserted-by":"crossref","first-page":"29729","DOI":"10.1074\/jbc.M112.367581","article-title":"Inhibition of pokeweed antiviral protein (PAP) by turnip mosaic virus genome-linked protein (VPg)","volume":"287","author":"Domashevskiy","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.05.019_b0215","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.4049\/jimmunol.177.12.8658","article-title":"Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection","volume":"177","author":"Hazrati","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2014.05.019_b0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbrc.2010.06.020","article-title":"Access to gram scale amounts of functional globular adiponectin from E. coli inclusion bodies by alkaline-shock solubilization","volume":"16","author":"Heiker","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2014.05.019_b0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1101\/gr.4.5.299","article-title":"Efficient gene synthesis by Klenow assembly\/extension-Pfu polymerase amplification (KAPPA) of overlapping oligonucleotides","volume":"4","author":"Holowachuk","year":"1995","journal-title":"Genome Res."},{"key":"10.1016\/j.antiviral.2014.05.019_b0045","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1371\/journal.pntd.0001133","article-title":"New antipoverty drugs, vaccines, and diagnostics: a research agenda for the US President\u2019s Global Health Initiative (GHI)","volume":"5","author":"Hotez","year":"2011","journal-title":"PLos Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2014.05.019_b0050","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00249-011-0726-z","article-title":"Investigating the effect of a single glycine to alanine substitution on interactions of antimicrobial peptide latarcin 2a with a lipid membrane","volume":"40","author":"Idiong","year":"2011","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.antiviral.2014.05.019_b0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virusres.2012.10.032","article-title":"Inhibition of Japanese encephalitis virus infection in vitro and in vivo by pokeweed antiviral protein","volume":"171","author":"Ishag","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2014.05.019_b0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Hancock peptide antimicrobial agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2014.05.019_b0065","series-title":"Arbovirus: Epidemiology and Ecology","first-page":"137","article-title":"Chikungunya virus disease","author":"Jupp","year":"1988"},{"key":"10.1016\/j.antiviral.2014.05.019_b0070","doi-asserted-by":"crossref","first-page":"20983","DOI":"10.1074\/jbc.M602168200","article-title":"Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity","volume":"281","author":"Kozlov","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.05.019_b0075","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI40104","article-title":"Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages","volume":"120","author":"Labadie","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.05.019_b0080","doi-asserted-by":"crossref","first-page":"12835","DOI":"10.1021\/bi026127d","article-title":"Design of non-cysteine-containing antimicrobial \u03b2-hairpins:structure\u2013activity relationship studies with linear protegrin-1 analogues","volume":"41","author":"Lai","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2014.05.019_b0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10529-009-0167-2","article-title":"Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro","volume":"32","author":"Liang","year":"2009","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.antiviral.2014.05.019_b0090","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1086\/587841","article-title":"Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alpha virus","volume":"197","author":"Lidbury","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.antiviral.2014.05.019_b0095","doi-asserted-by":"crossref","first-page":"e66084","DOI":"10.1371\/journal.pone.0066084","article-title":"A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells","volume":"8","author":"Lim","year":"2013","journal-title":"PLos One"},{"key":"10.1016\/j.antiviral.2014.05.019_b0220","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1089\/088922203322493049","article-title":"The theta-defensin, retrocyclin, inhibits HIV-1 entry","volume":"19","author":"Munk","year":"2003","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2014.05.019_b0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1358\/dof.2010.035.03.1452077","article-title":"Peptide-based antifungal therapies against emerging infections","volume":"35","author":"Matejuk","year":"2010","journal-title":"Drugs Future"},{"key":"10.1016\/j.antiviral.2014.05.019_b0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000238875","article-title":"Direct virus inactivation of tachyplesin I and its isopeptides from horseshoe crab hemocytes","volume":"37","author":"Murakami","year":"1991","journal-title":"Chemotheraphy"},{"key":"10.1016\/j.antiviral.2014.05.019_b0110","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature04051","article-title":"Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus","volume":"437","author":"Mygind","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.05.019_b0115","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/aid.2004.20.1157","article-title":"RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates","volume":"20","author":"Owen","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"9","key":"10.1016\/j.antiviral.2014.05.019_b0120","doi-asserted-by":"crossref","first-page":"e2405","DOI":"10.1371\/journal.pntd.0002405","article-title":"Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus","volume":"7","author":"Parashar","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2014.05.019_b0125","first-page":"37","article-title":"Evaluation of diagnostic tests: dengue","volume":"30","author":"Peeling","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2014.05.019_b0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/nar\/gkm219","article-title":"Optimizer: a web server for optimizing the codon usage of DNA sequences","volume":"35","author":"Puigb","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2014.05.019_b0135","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/nar\/gkm831","article-title":"HEG-DB: a data of predict highly expressed genes in prokaryotic complete genomes under translational selection","volume":"36","author":"Puigb","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2014.05.019_b0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/prep.1999.1084","article-title":"High-level expression and purification of biologically active recombinant pokeweed antiviral protein","volume":"16","author":"Rajamohan","year":"1999","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.antiviral.2014.05.019_b0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0022172400044442","article-title":"The New ala epidemic, III: the virus: isolation, pathogenic properties and relationship to the epidemic","volume":"54","author":"Ross","year":"1956","journal-title":"J. Hyg."},{"key":"10.1016\/j.antiviral.2014.05.019_b0150","first-page":"314","article-title":"Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells","volume":"12","author":"Rothan","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.antiviral.2014.05.019_b0155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2334-12-314","article-title":"Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1","volume":"12","author":"Rothan","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.05.019_b0160","doi-asserted-by":"crossref","DOI":"10.1089\/omi.2013.0056","article-title":"Anti-viral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide","volume":"17","author":"Rothan","year":"2013","journal-title":"OMICS J. Integr. Biol."},{"key":"10.1016\/j.antiviral.2014.05.019_b0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pep.2008.03.011","article-title":"Bacterial production of latarcin 2a, a potent antimicrobial peptide from spider venom","volume":"60","author":"Shlyapnikov","year":"2008","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.antiviral.2014.05.019_b0170","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/prep.2001.1416","article-title":"Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2","volume":"22","author":"Sijwali","year":"2001","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.antiviral.2014.05.019_b0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.virol.2009.07.024","article-title":"Replication cycle of chikungunya: a re-emerging arbovirus","volume":"393","author":"Solignat","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2014.05.019_b0185","first-page":"409","article-title":"Outbreak and spread of chikungunya","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.antiviral.2014.05.019_b0190","unstructured":"World Health Organization, 2013. Chikungunya in the French part of the Caribbean isle of Saint Martin. <http:\/\/www.who.int\/csr\/don\/2013_12_10a\/en\/>."},{"key":"10.1016\/j.antiviral.2014.05.019_b0200","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1128\/JVI.78.10.5147-5156.2004","article-title":"Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry","volume":"78","author":"Yasin","year":"2004","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2014.05.019_b0205","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.05.019_b0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-4690-8-28","article-title":"Antiviral activity of a-helical stapled peptides designed from the HIV-1 capsid dimerization domain","volume":"8","author":"Zhang","year":"2011","journal-title":"Retrovirology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214001612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214001612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T12:53:00Z","timestamp":1538571180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214001612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":42,"alternative-id":["S0166354214001612"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.05.019","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effects of a peptide-fusion protein (Latarcin\u2013PAP1\u2013Thanatin) against chikungunya virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}